News Category:

Drug Announcements

A bioactive molecule may protect against congestive heart failure

Scientists have shown that by giving mice a form of the fatty acid-derived bioactive molecule called lipoxin, improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response without altering the acute phase. This suggests lipoxin may have ...

CFDRC Release Video Featuring SynVivo in Action

 

CFDRC Developing Physiologically Realistic in vitro Tumor Microenvironment Platform

SynVivo-Tumor offers real-time analysis and visualization of drug delivery and cellular interactions and was showcased at the December ASCB meeting in San Francisco.

Birmingham’s Vivo Biosciences honored for innovation

By Stan Diel, al.com Exerpt: BIRMINGHAM, Alabama - Birmingham-based biotech company Vivo Biosciences has been credited with one of the top 10 innovations of 2012 by The Scientist magazine. Click here to read the full story.
news categories: ,

Soluble Therapeutics to Launch HSC Technology at BioProcess International Conference

Soluble Therapeutics to Launch HSC Technology at BioProcess International Conference

news categories:

Scientific discovery at USA College of Medicine leads to new biotech company

A scientific discovery made at the University of South Alabama College of Medicine has helped launch a new biotech company in Mobile.

CFDRC Developing Cell-based Microchip to Study Drug Interactions with the Blood-Brain Barrier

CFDRC Developing Cell-based Microchip to Study Drug Interactions with the Blood-Brain Barrier SynVivo-BBB is a new in vitro blood-brain barrier model offering real-time visualization of drug delivery and cellular interactions under physiologically realistic conditions. HUNTSVILLE, Ala. June 21, 2012 - CFD Research Corporation (CFDRC) has been awarded a $1.3M grant from the National Institutes of Health to ...